CellPoint
Holding Companies & Conglomerates · 11-50 Employees
View Company Info for Free
Overview
Phone Number
+61 893454555Website
www.cellpoint.comRevenue
<$5 MillionIndustry
About CellPoint
CellPoint Org Chart
Is CellPoint your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at CellPoint
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once CellPoint has new funding data
Product Launch: Get notified when CellPoint launches new products
Earning: See what the market has to say on CellPoint recently announced quarterly report
Check if CellPoint has recently received funding, and reach out quickly before it becomes old news!
Click to see if CellPoint had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if CellPoint is spiking on competitors!
CellPoint, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined CellPoint as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
CellPoint is experiencing very low activity levels compared to other companies in the Holding Companies & Conglomerates sector.
What does this means?
CellPoint is drawing exceptional interest within the Holding Companies & Conglomerates industry, suggesting notable developments or strong market momentum, learn more about CellPoint.
CellPoint Tech Stack
A closer look at the technologies used by CellPoint
CellPoint News & Media
+ND Capital exits CellPoint, via sale to Belgian biotech company Galapagos
“This deal is further validation of our strategy to invest in company creation in Europe," said Patrick Aebischer, Senior Partner at +ND Capital.+ND Capital's European Investment Strategy Delivers Again as Sale of CellPoint to Galapagos Paves the Way for Disruptive Point-of-Care Cell Therapy Model for Cancer Patients
Lausanne-based +ND Capital's investment strategy delivers again as Galapagos acquires CellPoint for €125m cash upfront and up to €100m in milestone payments Potential for paradigm shift in CAR-T therapy with CellPoint's decentralized point-of-care manufacturing model, in collaboration...
Top Holding Companies & Conglomerates Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CellPoint
CellPoint.com is currently reserved for strategic use and is open to qualified inquiries that align with their valuation and usage standards. The company appears to be focused on maintaining a specific strategic direction. Details about their products and services are not provided. They invite inquiries that meet their criteria.... Read More